Copertina

Do patients with migraine and obesity receive different treatments? Insights from real‐world data

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Keshet Pardo, Maor Mermelstein, Gal Tsur, Shlomit Yust‐Katz
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Cardiovascular risk and triptan usage among patients with migraine
di: Ido Peles, et al.
Pubblicazione: (2025)

Comparative analysis of real‐world acute prescription migraine therapy outcomes: Insights from the HeAD – US study
di: Devin Teichrow, et al.
Pubblicazione: (2026)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
di: Chia‐Chun Chiang, et al.
Pubblicazione: (2024)

Patient reported outcomes and the real‐world use of calcitonin gene–related peptide medications in migraine
di: Samuel K. Peasah, et al.
Pubblicazione: (2024)

Temporary occipital nerve stimulation as transitional therapy for chronic intractable cluster headache: A case report and proof of concept
di: Keshet Pardo, et al.
Pubblicazione: (2026)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
di: Andrew Blumenfeld, et al.
Pubblicazione: (2024)

The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model
di: Philip Victor Reducha, et al.
Pubblicazione: (2024)

Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham‐controlled study
di: Nan Cheng, et al.
Pubblicazione: (2025)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
di: Yunus Emre Meydanal, et al.
Pubblicazione: (2025)

Integrating gepants into clinical practice for the acute treatment of migraine
di: Richard B. Lipton, et al.
Pubblicazione: (2026)

Useful considerations for treating migraine in patients with autism
di: Sinifunanya E. Nwaobi
Pubblicazione: (2026)

A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine
di: Ye Su, et al.
Pubblicazione: (2024)

Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program
di: Idris Demirsoy, et al.
Pubblicazione: (2025)

Afterimage duration differs for migraine with or without aura
di: Florian Rimmele, et al.
Pubblicazione: (2025)

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study
di: Julia Peris‐Subiza, et al.
Pubblicazione: (2025)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
di: Susan Hutchinson, et al.
Pubblicazione: (2026)

Microneedles for the treatment of migraine and orofacial pain: A narrative review
di: Baicheng Cao, et al.
Pubblicazione: (2026)

Delayed urticaria during treatment with anti‐ CGRP monoclonal antibodies in migraine
di: Christoph T. Berger, et al.
Pubblicazione: (2026)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
di: Jessica Ailani, et al.
Pubblicazione: (2024)

Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
di: Antonio Munafò, et al.
Pubblicazione: (2026)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
di: Andrea M. Kuczynski, et al.
Pubblicazione: (2025)

Do antithrombotic drugs have a role in migraine prevention? A systematic review
di: Federico De Santis, et al.
Pubblicazione: (2025)

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
di: Anna Gryglas‐Dworak, et al.
Pubblicazione: (2024)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
di: Graham A. McLeod, et al.
Pubblicazione: (2025)

Heavy metal and trace element alterations in patients during a migraine attack
di: Sevilay Vural, et al.
Pubblicazione: (2024)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
di: Lawrence C. Newman, et al.
Pubblicazione: (2025)

No differences in subcortical volume between people with and without migraine: A REFORM study
di: Basit Ali Chaudhry, et al.
Pubblicazione: (2025)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
di: Richard B. Lipton, et al.
Pubblicazione: (2025)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
di: Joanna K. Bougie, et al.
Pubblicazione: (2024)

Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review
di: Stephen Silberstein, et al.
Pubblicazione: (2026)

Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study
di: Seonyoung Kang, et al.
Pubblicazione: (2024)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
di: Jessica Ailani, et al.
Pubblicazione: (2026)

Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation
di: Vishwesh Vishnu Naik, et al.
Pubblicazione: (2025)

Plain Language Summary Publication: Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine
di: Yukihisa Suzuki, et al.
Pubblicazione: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
di: Rikki Mangrum, et al.
Pubblicazione: (2024)

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department
di: Geneviève Tourigny‐Ruel, et al.
Pubblicazione: (2026)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
di: Richard B. Lipton, et al.
Pubblicazione: (2025)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
di: Muneto Tatsumoto, et al.
Pubblicazione: (2024)

Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”
Pubblicazione: (2025)

Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
di: Dawn C. Buse, et al.
Pubblicazione: (2024)